Skip to main content
Journal cover image

Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.

Publication ,  Journal Article
Vokes, EE; Leopold, KA; Herndon, J; Green, MR
Published in: Semin Oncol
June 1997

Chemotherapy has been shown to prolong the survival of patients with stage III non-small cell lung cancer. In particular, cisplatin and vinblastine administered before definitive radiotherapy results in a significant prolongation of median survival and increases the 2-year survival rate. Concomitant chemoradiotherapy also holds promise. Recently, several new active agents and combinations have been described for the treatment of stage III disease. The integration of these drugs and novel regimens into treatment plans for stage III non-small cell lung cancer is of great interest and a focus of current clinical investigations. Early data from these clinical trials are reviewed here.

Duke Scholars

Published In

Semin Oncol

ISSN

0093-7754

Publication Date

June 1997

Volume

24

Issue

3 Suppl 8

Start / End Page

S8-42-S8-45

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Humans
  • Combined Modality Therapy
  • Cisplatin
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Combined Chemotherapy Protocols
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vokes, E. E., Leopold, K. A., Herndon, J., & Green, M. R. (1997). Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer. Semin Oncol, 24(3 Suppl 8), S8-42-S8-45.
Vokes, E. E., K. A. Leopold, J. Herndon, and M. R. Green. “Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.Semin Oncol 24, no. 3 Suppl 8 (June 1997): S8-42-S8-45.
Vokes EE, Leopold KA, Herndon J, Green MR. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer. Semin Oncol. 1997 Jun;24(3 Suppl 8):S8-42-S8-45.
Vokes, E. E., et al. “Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.Semin Oncol, vol. 24, no. 3 Suppl 8, June 1997, pp. S8-42-S8-45.
Vokes EE, Leopold KA, Herndon J, Green MR. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer. Semin Oncol. 1997 Jun;24(3 Suppl 8):S8-42-S8-45.
Journal cover image

Published In

Semin Oncol

ISSN

0093-7754

Publication Date

June 1997

Volume

24

Issue

3 Suppl 8

Start / End Page

S8-42-S8-45

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Humans
  • Combined Modality Therapy
  • Cisplatin
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Combined Chemotherapy Protocols
  • 1112 Oncology and Carcinogenesis